Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03111732
Brief Title: Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)

First Submitted : April 12, 2017
First Submitted that Met QC Criteria : April 12, 2017
First Posted : April 13, 2017

Last Update Submitted that Met QC Criteria : February 11, 2020
Last Update Posted : February 12, 2020